13-hydroxy-3-oxo-olean-11-en-28-oic acid - Compound Card

13-hydroxy-3-oxo-olean-11-en-28-oic acid

Select a section from the left sidebar

13-hydroxy-3-oxo-olean-11-en-28-oic acid

Structure
Zoomed Structure
  • Family: Plantae - Verbenaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Pentacyclic Triterpenoid
Canonical Smiles OC(=O)[C@]12CC[C@@]3(C(C2CC(CC1)(C)C)(O)C=CC1[C@@]3(C)CCC2[C@]1(C)CCC(=O)C2(C)C)C
InChI InChI=1S/C30H46O4/c1-24(2)14-16-29(23(32)33)17-15-28(7)27(6)12-8-19-25(3,4)22(31)10-11-26(19,5)20(27)9-13-30(28,34)21(29)18-24/h9,13,19-21,34H,8,10-12,14-18H2,1-7H3,(H,32,33)/t19?,20?,21?,26-,27+,28-,29-,30?/m0/s1
InChIKey NFXOTMZBYZYFBR-ZNKFUYKASA-N
Formula C30H46O4
HBA 3
HBD 2
MW 470.69
Rotatable Bonds 1
TPSA 74.6
LogP 6.41
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 34
Formal Charge 0
Fraction CSP3 0.87
Exact Mass 470.34
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Lantana montevidensis Verbenaceae Plantae 1241423

Showing of synonyms

  • Mohamed NM, Makboul MA, et al. (2015). New pentacyclic triterpenoid from the roots of Lantana montevidensis (spreng.) briq. cultivated in Egypt. Planta Medica,2015,81-PC22. [View]
Pubchem: 162817004
Nmrshiftdb2: 70103562

No compound-protein relationship available.

Structure

SMILES: C1C(=O)CCC2C1CCC(C23)C4C(C=C3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 470.69 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.52
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.73
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.4

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
1.72
Plasma Protein Binding
84.91
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
3.59
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.9
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.55
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
3.42
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-110.19
Rat (Acute)
2.32
Rat (Chronic Oral)
2.06
Fathead Minnow
3.98
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
465.06
Hydration Free Energy
-2.6
Log(D) at pH=7.4
4.07
Log(P)
5.38
Log S
-5.84
Log(Vapor Pressure)
-8.65
Melting Point
285.08
pKa Acid
4.63
pKa Basic
7.81
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 3 0.8821
CmeR Q7B8P6 Q7B8P6_CAMJU Campylobacter jejuni 3 0.8821
Avidin P02701 AVID_CHICK Gallus gallus 3 0.8754
Avidin P02701 AVID_CHICK Gallus gallus 3 0.8754

Download SDF